語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Guide to targeted therapies[electron...
~
Cappuzzo, Federico.
Guide to targeted therapies[electronic resource] :treatment resistance in lung cancer /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
616.9942406
書名/作者:
Guide to targeted therapies : treatment resistance in lung cancer // by Federico Cappuzzo.
作者:
Cappuzzo, Federico.
出版者:
Cham : : Springer International Publishing :, 2015.
面頁冊數:
vii, 67 p. : : ill., digital ;; 24 cm.
Contained By:
Springer eBooks
標題:
Lungs - Cancer
標題:
Epidermal growth factor.
標題:
Medicine & Public Health.
標題:
Oncology.
ISBN:
9783319207414
ISBN:
9783319207407
內容註:
Introduction -- Therapy options for advanced NSCLC -- Resistance to EGFR TKIs -- Overcoming EGFR-TKI resistance -- Resistance to crizotinib and therapeutic options -- Resistance to angiogenic drugs and therapeutics options -- Conclusions.
摘要、提要註:
This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide.
電子資源:
http://dx.doi.org/10.1007/978-3-319-20741-4
Guide to targeted therapies[electronic resource] :treatment resistance in lung cancer /
Cappuzzo, Federico.
Guide to targeted therapies
treatment resistance in lung cancer /[electronic resource] :by Federico Cappuzzo. - Cham :Springer International Publishing :2015. - vii, 67 p. :ill., digital ;24 cm.
Introduction -- Therapy options for advanced NSCLC -- Resistance to EGFR TKIs -- Overcoming EGFR-TKI resistance -- Resistance to crizotinib and therapeutic options -- Resistance to angiogenic drugs and therapeutics options -- Conclusions.
This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide.
ISBN: 9783319207414
Standard No.: 10.1007/978-3-319-20741-4doiSubjects--Topical Terms:
447997
Lungs
--Cancer
LC Class. No.: RC280.L8
Dewey Class. No.: 616.9942406
Guide to targeted therapies[electronic resource] :treatment resistance in lung cancer /
LDR
:01594nam a2200313 a 4500
001
444388
003
DE-He213
005
20160408161554.0
006
m d
007
cr nn 008maaau
008
160715s2015 gw s 0 eng d
020
$a
9783319207414
$q
(electronic bk.)
020
$a
9783319207407
$q
(paper)
024
7
$a
10.1007/978-3-319-20741-4
$2
doi
035
$a
978-3-319-20741-4
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC280.L8
072
7
$a
MJCL
$2
bicssc
072
7
$a
MED062000
$2
bisacsh
082
0 4
$a
616.9942406
$2
23
090
$a
RC280.L8
$b
C249 2015
100
1
$a
Cappuzzo, Federico.
$3
635901
245
1 0
$a
Guide to targeted therapies
$h
[electronic resource] :
$b
treatment resistance in lung cancer /
$c
by Federico Cappuzzo.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Adis,
$c
2015.
300
$a
vii, 67 p. :
$b
ill., digital ;
$c
24 cm.
505
0
$a
Introduction -- Therapy options for advanced NSCLC -- Resistance to EGFR TKIs -- Overcoming EGFR-TKI resistance -- Resistance to crizotinib and therapeutic options -- Resistance to angiogenic drugs and therapeutics options -- Conclusions.
520
$a
This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide.
650
0
$a
Lungs
$x
Cancer
$x
Treatment.
$3
447997
650
0
$a
Epidermal growth factor.
$3
635902
650
1 4
$a
Medicine & Public Health.
$3
463493
650
2 4
$a
Oncology.
$3
205017
710
2
$a
SpringerLink (Online service)
$3
463450
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-20741-4
950
$a
Medicine (Springer-11650)
筆 0 讀者評論
多媒體
多媒體檔案
http://dx.doi.org/10.1007/978-3-319-20741-4
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入